Clinical Trial Update: A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) [Phase 2]

View source ↗

Summary

This document describes a Phase 2, single-arm, open-label pilot trial of Zanidatamab (ZW25) for early-stage HER2-positive breast cancer, which is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zanidatamab (ZW25) (zanidatamab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer, HER2-positive | Phase 2 | Status: RECRUITING